TRELSTAR

LOE Approaching

triptorelin pamoate

NDAINTRAMUSCULARINJECTABLE
Approved
Jun 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4

Clinical Trials (4)

NCT05590793Phase 3Completed

Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

Started Nov 2022
195 enrolled
Advanced Prostate CancerMetastatic Prostate CancerLocally Advanced Prostate Cancer
NCT03232281Phase 3Completed

Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis

Started Jul 2017
300 enrolled
Endometriosis
NCT01715129Phase 3Completed

Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer

Started Jan 2013
126 enrolled
Prostate Cancer
NCT00909844Phase 3Completed

Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study

Started Apr 2008
35 enrolled
Precocious Puberty